Legal Representation
Attorney
Nichole T. Hayden
USPTO Deadlines
Next Deadline
140 days remaining
NOA E-Mailed - SOU Required
Due Date
December 17, 2025
Extension Available
Until June 17, 2026
Application History
14 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 17, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 22, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 22, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 16, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 27, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 26, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 26, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 26, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 14, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 14, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 14, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 31, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 15, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 15, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Biochemical preparations for scientific purposes, namely, in vitro scientific or research use; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use
Class 005
Biologics in the nature of pharmaceutical preparations for treatment of chronic skin diseases such as plaque psoriasis, psoriatic arthritis, and other dermatologic and inflammatory indications; Antibodies for medical purposes, namely, for treatment of chronic skin diseases such as plaque psoriasis, psoriatic arthritis, and other dermatologic and inflammatory indications; Therapeutic pharmaceutical for the treatment of chronic skin diseases such as plaque psoriasis, psoriatic arthritis, and other dermatologic and inflammatory indications
Class 042
Biotechnology research related to antibodies and therapies for treatment of chronic skin diseases such as plaque psoriasis, psoriatic arthritis, and other dermatologic and inflammatory indications
Classification
International Classes
001
005
042